204 related articles for article (PubMed ID: 4448138)
1. [Treatment of primary idiopathic hemochromatosis and secondary hemosiderosis].
Strohmeyer G
Dtsch Med Wochenschr; 1974 Nov; 99(45):2295-9. PubMed ID: 4448138
[No Abstract] [Full Text] [Related]
2. [Hemosiderosis and idiopathic hemochromatosis].
Nowotny P
Z Gesamte Inn Med; 1967 Dec; 22(24):799-806. PubMed ID: 5585476
[No Abstract] [Full Text] [Related]
3. [Pathogenesis, clinical aspects and therapy of siderophilia (hemochromatosis)].
Dökert B; Schwenke R
Z Arztl Fortbild (Jena); 1971 Sep; 65(17):881-6. PubMed ID: 4946947
[No Abstract] [Full Text] [Related]
4. [Therapy of hemochromatosis].
Stremmel W; Niederau C; Strohmeyer G
Dtsch Med Wochenschr; 1988 Oct; 113(42):1648-50. PubMed ID: 3181017
[No Abstract] [Full Text] [Related]
5. [Present aspects of the treatment of hemochromatosis (apropos of 100 observations)].
Darnis F; Mossé A; Breauté C; Delorme ML
Ann Med Interne (Paris); 1971 Dec; 122(12):1193-210. PubMed ID: 5151624
[No Abstract] [Full Text] [Related]
6. [Desferrioxamine in patients with hemochromatosis and hemosiderosis].
Maspes V; Tamigaki M; Gomes ZJ; Jamra M
Rev Hosp Clin Fac Med Sao Paulo; 1966; 21(4):181-95. PubMed ID: 5918167
[No Abstract] [Full Text] [Related]
7. [Use of desferal in anemia, myeloid leukemia and other pathological conditions].
Kol'tsova GN; Meshchanov AIu
Gematol Transfuziol; 1992; 37(9-10):44-6. PubMed ID: 1490576
[No Abstract] [Full Text] [Related]
8. [The treatment of idiopathic hemochromatosis by means of blood removal and chelates (author's transl)].
Brodanová M; Bednár D
Cas Lek Cesk; 1974 Apr; 113(15):465-9. PubMed ID: 4828196
[No Abstract] [Full Text] [Related]
9. [Use of desferal in treatment of sideroses of different origin. (Literature review)].
Turbina NS
Probl Gematol Pereliv Krovi; 1968 Jul; 13(7):47-52. PubMed ID: 4898933
[No Abstract] [Full Text] [Related]
10. [Guidelines for diagnosis and treatment of secondary iron overload in patients with congenital anemia].
Cario H; Grosse R; Janssen G; Jarisch A; Meerpohl J; Strauss G;
Klin Padiatr; 2010 Nov; 222(6):399-406. PubMed ID: 20862634
[TBL] [Abstract][Full Text] [Related]
11. [Use of desferrioxamine B in normal subjects and in patients with increased iron storage].
Muranda M; Velasco M; Giménez E; Ruiz J; Bastías E; Rodriguez J; Etcheverry R; Guzmán C; Regonesi C; Janklevich S
Rev Med Chil; 1965 Apr; 93(4):127-33. PubMed ID: 5832943
[No Abstract] [Full Text] [Related]
12. Desferal therapy in iron storage disease.
Thompson RB; Owen DM; Bell WN
Am J Med Sci; 1967 Apr; 253(4):453-60. PubMed ID: 6021380
[No Abstract] [Full Text] [Related]
13. [Further experiences with iron-chelating therapy (desferrioxamine and ascorbic acid) in siderochromatosis and Cooley's disease].
Cartei G; Cazzavillan M; Chisesi T; Battista R; Barbui T; Dini E
Minerva Med; 1978 Mar; 69(13):811-21. PubMed ID: 643223
[No Abstract] [Full Text] [Related]
14. The treatment of hemosiderosis in thalassaemia major with desferrioxamine-B.
Kirimlidis S; Philippidis P; Drossos C; Economidis J
Helv Paediatr Acta; 1966 Sep; 21(4):343-50. PubMed ID: 5997620
[No Abstract] [Full Text] [Related]
15. Ultrastructure of the liver in idiopathic haemosiderosis and results of a treatment by repeated bleedings.
Prunescu CC; Prunescu P; Vîlcu AL
Morphol Embryol (Bucur); 1987; 33(2):133-6. PubMed ID: 2956507
[No Abstract] [Full Text] [Related]
16. Iron overload disorders: natural history, pathogenesis, diagnosis, and therapy.
McLaren GD; Muir WA; Kellermeyer RW
Crit Rev Clin Lab Sci; 1983; 19(3):205-66. PubMed ID: 6373141
[TBL] [Abstract][Full Text] [Related]
17. [Use of desferal and some data on hemosiderosis in hypo- and aplastic anemias].
Fainshtein FE; Trubina NS; Sobaleva IuG; Rozanova NS; Voronina AN
Probl Gematol Pereliv Krovi; 1968 Aug; 13(8):31-8. PubMed ID: 5736846
[No Abstract] [Full Text] [Related]
18. [Treatment and prevention of chronic iron overload (author's transl)].
Brissot P; Bourel M; Simon M
Gastroenterol Clin Biol; 1981 Dec; 5(12):1108-19. PubMed ID: 7319207
[No Abstract] [Full Text] [Related]
19. [Specific treatment of excessive iron deposition in the tissues].
Plachecka-Gutowska M; Mikolajew M
Pol Arch Med Wewn; 1965; 35(1):111-7. PubMed ID: 5900073
[No Abstract] [Full Text] [Related]
20. Iron metabolism and chelation therapy in hemosiderosis.
Graziano JH
Curr Top Hematol; 1978; 1():127-50. PubMed ID: 400529
[No Abstract] [Full Text] [Related]
[Next] [New Search]
